View drug registration information details.
Items | Registration information |
ID | 1086 |
No | 1086 |
Brand Name | TELI 40 |
Ingredients | TELMISARTAN BP 40 MG |
Dosage Form | TABLET |
Primary Packaging | ALU-ALU BLISTER |
Storage | STORE BELOW 30 C |
Shelf Life | 3 YEARS |
Pack Size | BOX OF 1 X 10'S, 3 X 10'S AND 50 X 10'S |
Dispensing Category | Prescription only |
ATC Classification | C09CA07 |
Pharmaceutical Class | ANTIHYPERTENSIVE |
Indications | TREATMENT OF ESSENTIAL HYPERTENSION IN ADULTS, CARDIOVASCULAR PREVENTION. |
Contraindications | HYPERSENSITIVITY, SECOND AND THIRD TRIMESTER OF PREGNANCY, BILIARY OBSTRUCTIVE DISORDER, SEVERE HEPATIC IMPAIRMENT |
Side Effects | ANAEMIA, HYPERKALAEMIA, INSOMNIA, DEPRESSION, VERTIGO, BRADYCARDIA, HYPOTENTION, DYSPNOEA,ABDOMINAL PAIN, DIARRHEA, DYSPEPSIA, FLATULENCE, VOMITING, DRY MOUTH |
Unit Price | |
EDL |
No |
Description | WHITE TO OFF WHITE, OVAL, UNCOATED, BICONVEX TABLET, PLAIN ON BOTH SIDES |
Note | |
License Owner | IC Pharma Lao Co., Ltd |
Manufacturer | CADILA PHARMACEUTICALS LIMITED |
Country | INDIA |
Import Registration No | MFG/CADILA/16783/B |
Import Registration Date | 2018-02-14 |
Activity | CERTIFICATE RELEASED |
Applied Date | 2021-12-10 |
FDD Registration No | 03 I 5409/23 |
FDD Registration Date | 2023-03-17 |
Expiry Date | 2026-03-16 |
Back to drug list
|